person
as of 2026-07-01Huafang Li, MD, PhD
Huafang LI, MD,PhD
ORCID 0000-0002-4357-7614
at a glance
Roles: Principal Investigator, Study Director, Author
KOL signal score 3
2 publications · 0 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Drug Clinical Trial Office, Shanghai Mental Health Center
Roles
Principal Investigator, Study Director, Author
KOL signal
3
Publications
2 (0 high-value)
Trial investigator
no
Publishes on
1 drugs
Trials led
3
A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia
NCT00866645Phase 2, Phase 3Completed
A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia
NCT00817648Phase 4Completed
Publications & congress
2
Patterns of Serum Prolactin Elevation Associated with Nine Second-Generation Antipsychotics in a Large Cohort of Patients with Schizophrenia.
CNS drugs · 2025
Comparative risk of QTc prolongation induced by second-generation antipsychotics in the real world: retrospective cohort study based on a hospital information system.
BJPsych open · 2025
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
drug
STUDY_DIRECTOR